New study aims to unlock secrets of pneumonia in the elderly
NCT ID NCT07070284
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 500 elderly patients (65 and older) with severe pneumonia to understand why some recover and others don't. Researchers will review medical records from hospitals across Europe, focusing on death rates and complications. No new drugs or treatments are being tested—the goal is to learn from real-world data to improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better predict and manage severe pneumonia in older adults, leading to improved care guidelines.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove that any specific intervention works, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARNAS Civico-Di Cristina-Benfratelli Hospital - Infectious Diseases Unit
Palermo, Sicily, 90127, Italy
-
ASST del Garda - Ospedale Civile "La Memoria" di Gavardo
Gavardo, Lombardy, 25085, Italy
-
Azienda Ospedaliero-Universitaria Pisana
Pisa, Tuscany, 56126, Italy
-
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Rome, Lazio, 00161, Italy
-
Azienda Ospedaliero-Universitaria di Modena
Modena, Emilia-Romagna, 41124, Italy
-
Bellvitge Universitary Hospital
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Centre Hospitalier Intercommunal Hôpitaux du Pays du Mont-Blanc - Site de Chamonix
Chamonix, 74400, France
-
Centre Hospitalier de Melun
Melun, 77000, France
-
Centre hospitalier Alpes Léman
Contamine-sur-Arve, 74130, France
-
Centro Hospitalar Universitário de São João (CHUSJ)
Porto, 4200-319, Portugal
-
Corporació Sanitària Parc Taulí
Sabadell, Catalunuya, 08208, Spain
-
Evangelismos General Hospital
Athens, 10676, Greece
-
Hospital Universitario Donostia
Donostia / San Sebastian, Gipuzkoa, 20014, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Andalusia, 41013, Spain
-
Hospital del Mar Barcelona
Barcelona, Catalonia, 08003, Spain
-
Hôpital Bichat - Claude-Bernard
Paris, 75018, France
-
Thibaut Fraisse
Alès, 30103, France
-
University Hospital for Infectious Diseases Dr. Fran Mihaljević
Zagreb, City of Zagreb, 10000, Croatia